mRNA

BIOLOGICAL2 trials

Sponsors

University Hospital Tuebingen

Conditions

Malignant MelanomaRecurrent Prostate Cancer

Phase 1

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

CompletedNCT00204607

University Hospital TuebingenMalignant Melanoma

Start: 2004-07-31End: 2007-01-31Target: 20Updated: 2007-04-19

Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy

University Hospital TuebingenRecurrent Prostate Cancer

Start: 2004-04-30End: 2017-10-31Updated: 2017-08-17